Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BRIP1 |
| Variant | Q554Hfs*35 |
| Impact List | frameshift |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | BRIP1 Q554Hfs*35 indicates a shift in the reading frame starting at amino acid 554 and terminating 35 residues downstream causing a premature truncation of the 1249 amino acid Brip1 protein (UniProt.org). Q554Hfs*35 has not been characterized, however, due to the effects of other truncation mutations downstream of Q554 (PMID: 18628483), is predicted to lead to a loss of Brip1 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
BRIP1 mutant BRIP1 inact mut BRIP1 Q554Hfs*35 |
| Transcript | NM_032043.3 |
| gDNA | chr17:g.61780969_61780972delAGTC |
| cDNA | c.1662_1665delGACT |
| Protein | p.Q554Hfs*35 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011525332.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525335.4 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525333.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525341.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| NM_032043.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436903.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525341.4 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436891.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436900.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436893.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525339.4 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525339.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525340.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525333.4 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525332.4 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525336.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436895.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525334.2 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436902.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436899.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525337.2 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525335.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436894.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525334.3 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525340.4 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436897.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436901.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| NM_032043.2 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_011525336.2 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436904.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436896.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| XM_047436892.1 | chr17:g.61780969_61780972delAGTC | c.1662_1665delGACT | p.Q554Hfs*35 | RefSeq | GRCh38/hg38 |
| Molecular Profile | Protein Effect | Treatment Approaches |
|---|---|---|
| BRIP1 Q554Hfs*35 | loss of function - predicted | Olaparib |